Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.
Launched by SVENDBORG HOSPITAL · Jan 8, 2017
Trial Information
Current as of August 15, 2025
Unknown status
Keywords
ClinConnect Summary
Coronary artery disease (CAD) is the leading cause of death and morbidity in type 2 diabetes mellitus (T2DM) and diabetics holds the same risk for death or myocardial infarction (MI) as patients with a prior (MI) without diabetes. In addition to macrovascular complications, and traditional cardiac risk factors, T2DM is burdened by microvascular dysfunction affecting several organs. The dynamics between microvascular dysfunction, known cardiac risk factors and coronary atherosclerosis in diabetic disease is not well characterized.
In the present study, a primary cohort of 300 type 2 diabeti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Type 1 or 2 diabetes mellitus
- • Ability to provide informed conscent
- Exclusion Criteria:
- • History of CAD
- • Symtoms of CAD (angina)
- • Any tachyarrhythmias making CCTA impossible
- • Glumerular filtration rate (GFR)\< 45 ml/min
- • Allergy to iodine contrast
- • Critical illness with life expectancy less than 1 year
- • Documented heart failure
About Svendborg Hospital
Svendborg Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Denmark, the hospital is committed to exploring new treatments and therapies across various medical disciplines, facilitating collaboration between healthcare professionals, researchers, and patients. With a focus on ethical practices and patient safety, Svendborg Hospital aims to contribute valuable insights to the scientific community while enhancing the quality of healthcare services in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Svendborg, Fyn, Denmark
Patients applied
Trial Officials
Kenneth Egstrup, Prof. DMSci
Study Director
Head of Reseach, Cardiovascular Research Unit, OUH Svendborg Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials